![Priya Singhal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Priya Singhal
Corporate Officer/Principal at
BIOGEN INC.
Net worth: 2 M $ as of 30/05/2026
Profile
Priya Singhal is currently Executive Vice President & Head-Development at Biogen, Inc. since 2021.
Formerly, Dr. Singhal was Head-Medical Affairs & Vice President at Vertex Pharmaceuticals, Inc. from 2008 to 2012, VP-Clinical Trials Benefit Risk Management at Biogen, Inc. from 2012 to 2018, and Head-Research & Development at Zafgen, Inc. from 2019 to 2020.
Education includes a doctorate from the University of Mumbai and graduate studies at Harvard T.H.
Chan School of Public Health.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOGEN INC. 0.01% | 20/04/2026 | 8,043 ( 0.01% ) | 2 M $ | 30/05/2026 |
Priya Singhal active positions
| Companies | Position | Start |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | - |
Former positions of Priya Singhal
| Companies | Position | End |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2019 |
| BIOGEN INC. | Corporate Officer/Principal | 31/12/2017 |
| VERTEX PHARMACEUTICALS INCORPORATED | Chief Tech/Sci/R&D Officer | 31/12/2011 |
Training of Priya Singhal
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
77
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard T.H. Chan School of Public Health
 Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Priya Singhal
